Fbw7 is a tumor suppressor that is mutated in numerous cancers. It encodes an E3 ubiquitin ligase, whose ability to decrease the levels of pivotal regulators of cell growth and proliferation underlies its tumor suppressor function. Here, we explore the consequences of Fbw7 inactivation on the outcome of chemotherapeutic treatments. When exposed to spindle toxins such as vinblastine and taxol, Fbw7-deficient cells undergo extensive mitotic slippage and endoreduplication, rendering them polyploid. A combined deregulation of several Fbw7 target proteins is required for this phenotype. Specifically, elevated expression of cyclin E and Aurora A in Fbw7-deficient cells is required for drug-induced polyploidy. However, overexpression of either cyclin E or Aurora A alone is not sufficient for drug-induced polyploidy. In addition, we demonstrate that Fbw7 deficiency limits the ability of p53 to respond to mitotic toxins but not to DNA damage. Furthermore, Fbw7 expression regulates the p53-dependent induction of genes such as Lats2 and p21 in response to vinblastine. Hence, we suggest that Fbw7 serves as a master regulator of the mitotic and tetraploidy checkpoints.
Introduction
The Fbw7/hCDC4 protein is the substrate specificity component of an Skp1-Cullin-F-Box ubiquitin ligase complex. Lesions in the Fbw7 gene have been observed in a large list of cancers (Moberg et al., 2001; Strohmaier et al., 2001; Spruck et al., 2002; Cassia et al., 2003; Ekholm-Reed et al., 2004; Rajagopalan et al., 2004; Kwak et al., 2005) . Its classification as a tumor suppressor is further underscored by experimental evidence demonstrating that the development of radiation-induced tumors in mice heterozygous for Fbw7 is greater than that in mice expressing two normal alleles (Mao et al., 2004) . Moreover, tumors derived from irradiated p53-heterozygous mice acquire mutations in the Fbw7 gene whereas tumors derived from p53 null mice do not (Mao et al., 2004) , suggesting a p53-dependent selective pressure for Fbw7 inactivation.
Concordant with a putative role for Fbw7 as a tumor suppressor, several known oncogenes such as the SV40 large T antigen and activated H-Ras negatively regulate Fbw7 activity Welcker and Clurman, 2005) .
The identification of several oncogenes, controlling cell growth and proliferation, as Fbw7 substrates explains, at least in part, its tumor suppression activity . In fact, Fbw7 was originally isolated by its ability to bind and promote ubiquitination of cyclin E phosphorylated at Thr 380 and Thr 62 (Koepp et al., 2001; Moberg et al., 2001; Strohmaier et al., 2001) . This finding explains the frequently elevated expression of cyclin E in breast tumors lacking active Fbw7 (Ekholm-Reed et al., 2004) . Other substrates include the oncoproteins c-Myc (Moberg et al., 2004; Welcker et al., 2004; Yada et al., 2004) , c-Jun (Nateri et al., 2004; Wei et al., 2005) and Notch (Gupta-Rossi et al., 2001; Oberg et al., 2001; Wu et al., 2001) , all of which act to increase cell volume, proliferation and de-differentiation. In addition, Aurora A kinase, an important regulator of mitosis that is frequently overexpressed in human cancer tissues, also serves as a substrate of Fbw7 (Mao et al., 2004; Fujii et al., 2006) . Interestingly, Aurora A can interact with and antagonistically phosphorylate two components of the p53 pathway (Chen et al., 2002) . p53 is phosphorylated at Ser 315 and Ser 215 by Aurora A. These phosphorylations reduce p53 levels and transcriptional activity (Katayama et al., 2004; Liu et al., 2004) . Aurora A also phosphorylates Lats2, a serine/threonine kinase considered to be a tumor suppressor which controls M phase transit and activation of the p53-dependent tetraploidy checkpoint (Toji et al., 2004; Aylon et al., 2006) .
Given the plethora of major regulators of proliferation that are controlled by Fbw7, we hypothesized that the inactivation of Fbw7 in various tumors might have far-reaching effects on the outcome of chemotherapeutic treatment. Indeed, in cells exposed to spindle toxins, Fbw7 expression is important for the maintenance of a proper M phase checkpoint, preventing mitotic slippage, endoreduplication and development of polyploidy. This effect is dependent on deregulation of at least two Fbw7 substrates, cyclin E and Aurora A, each of which is required, but not sufficient, to override the checkpoints activated by these drugs. Furthermore, the loss of Fbw7 attenuates the p53 transcriptional response to mitotic inhibitors. Moreover, Fbw7 expression reduces high basal p53 activity but expends its ability to respond to spindle toxins. Our findings define a new signaling axis in which Fbw7 is placed upstream of the Lats2 and p53 pathway in the prevention of tetraploidy upon exposure to microtubule poisons.
Results
Fbw7 activity is essential for prevention of mitotic slippage and polyploidy Information regarding cellular alterations affecting the cellular response to chemotherapy is extremely valuable. As Fbw7 is inactivated in human cancers, it was of interest to determine the consequences this inactivation on the cellular response to chemotherapy treatment. Toward that end, we used two cell systems: HCT116 cells expressing wild-type levels of Fbw7 (Fbw7 þ / þ ) and their derivatives from which the gene for Fbw7 had been knocked out (Fbw7 À/À ) (Rajagopalan et al., 2004) and HeLa cells in which the expression of Fbw7 had been knocked down by introducing an Fbw7-specific shRNA (HeLa Sh-Fbw7). This shRNA knocks down all three isoforms of Fbw7. Quantitative real-time PCR (qRT-PCR) analysis revealed that the inserted shRNA reduced Fbw7 mRNA expression by 80% relative to HeLa cells expressing the vector alone (Supplementary Figure S1 ).
Both cells types were exposed to various chemotherapeutic drugs, commonly used in the clinic and screened for cell-type independent effects of the drugs. Interestingly, such an effect was identified in response to drugs activating the mitotic checkpoint. Exposing control HeLa cells and Fbw7 þ / þ cells to vinblastine or taxol caused a robust arrest of cells with 4 N DNA content. Some polyploidy was observed in both cell types, ranging from less than 10% 24 h after treatment with 100 nM vinblastine to less than 20% 40 h after treatment with taxol ( Figure 1) . However, the polyploidy was markedly higher in both HeLa Sh-Fbw7 and HCT116 Fbw7 À/À cells after exposure to either drug, in comparison to their wild-type counterparts (Figure 1 ). In fact, the portion of Fbw7 À/À cells, carrying more than 4 N DNA content after taxol treatment was greater than the portion arrested with 4 N DNA content. These results demonstrate that Fbw7 plays an important role in the prevention of polyploidy. This effect is neither drug nor cell-type specific.
As Fbw7 À/À cells endoreduplicate, it is clear that the polyploidy checkpoint is compromised. However, since we scored for polyploidy, it was impossible to determine whether the lack of Fbw7 expression compromised only the activation of G 1 /S checkpoint, or also the M phase checkpoint. To determine Fbw7 effects on different stages of the cell cycle, we measured events characterizing specific stages of the cell cycle, that is, proteins whose expression or phosphorylation is changed at different stages. The expression level of cyclin B and phosphorylation of histone H3 were used as markers for mitosis, the expression of the mitotic checkpoint protein BUBR1 was monitored to detect activation of the mitotic checkpoint, and p27 level was used to determine the effect on the G 1 /S transition. As depicted in Figure 2 , both mitotic markers were induced significantly more in Fbw7 þ / þ cells after treatment with either vinblastine or taxol. Furthermore, the moderate increase in the levels of cyclin B in Fbw7 À/À cells was very transient and declined below the basal level by 24 h after treatment, unlike in Fbw7 þ / þ cells in which the decline was lower and levels higher than in untreated cells were maintained at this time point (Figure 2 ). This result suggested that the lack of Fbw7 increases mitotic slippage. This conclusion is further supported by the fact that BUBR1 expression was elevated to a lower extent and more transiently in the absence of Fbw7 expression (Figure 2) . Therefore, we conclude that both cell types respond to spindle toxins but the amplitude and duration of the mitotic arrest is reduced in the absence of Fbw7.
Next, we examined the levels of p27 in Fbw7 À/À and Fbw7 þ / þ cells before and after vinblastine and taxol treatments. In correlation with the efficient endoreduplication in Fbw7
À/À cells no induction of p27 is observed in these cells whereas elevated levels are observed in Fbw7-expressing cells (Figure 2 ). This result suggests that in addition to the mitotic arrest the G 1 arrest is also overridden in the absence of Fbw7 expression.
Absence of Fbw7 leads to overexpression of cyclin E and Aurora A To explore the mechanisms controlling the prevention of drug-induced polyploidy, we examined the expression levels of proteins whose stability is normally regulated by Fbw7. The levels of c-Jun, c-Myc, cyclin E and Aurora A were determined by immunoblotting in Fbw7 À/À and Fbw7 þ / þ cells before and after treatment with vinblastine as depicted in Figure 3 ; similar results were obtained with taxol (data not shown). While the effects on c-Jun and c-Myc expression in both cell lines were minor, the basal levels of Aurora A and cyclin E were considerably higher in Fbw7
À/À cells than in HCT116
þ / þ cells. In addition, whereas the high levels of cyclin E in Fbw7 À/À cells remained stable through the different treatments, Aurora A levels were transiently induced 12 h after taxol or vinblastine treatment. These results suggest that elevated levels of cyclin E and Aurora A, both of which are known inducers of chromosomal instability, may govern the establishment of polyploidy in Fbw7-deficient HCT116 and HeLa cells. (Waldman et al., 1996) . Since p53 responds to oncogenic stresses such as cyclin E deregulation (Deffie et al., 1995; Stewart et al., 1999) , unscheduled DNA replication (Bartkova et al., 2005) or microtubule disruption (Doxsey et al., 2005) , and has an essential role in the prevention of polyploidy (Di Leonardo et al., 1997; Aylon et al., 2006) , it was important to verify the functionality of p53 in HCT116 Fbw7 À/À cells. We measured the level and activity of p53 by determining its own level and the levels of its target gene product, Mdm2, in Fbw7 À/À and Fbw7 þ / þ cells before and after treatment with vinblastine. p53 was induced in both cell lines; however, in contrast to the induction observed in Fbw7 þ / þ cells, despite higher basal levels, Mdm2 was not induced by the drug in Fbw7 À/À cells ( Figure 3a ). These results suggested that the p53 in these cells is active; however, its response to mitotic inhibitors is limited. To support this notion, we also examined the induction of two additional p53 target-gene products, Lats2 and p21 cip1 . Lats2 is activated by mitotic apparatus damage, upon which it translocates from the centrosome to the nucleus, where Fbw7 activity prevents drug-induced polyploidy S Finkin et al it interacts with and inhibits Mdm2 to induce p53 (Aylon et al., 2006) . p21 cip1 is a well-characterized inhibitor of cell cycle progression. Similar to Mdm2, the basal levels of both Lats2 and p21 cip1 were elevated in Fbw7 À/À cells, yet further increase in their levels following exposure to vinbalstine was very limited in comparison to Fbw7 þ / þ cells ( Figure 3b ). To confirm that the limited induction of Lats2 was not confined to vinblastine treatment, Fbw7 þ / þ and Fbw7 À/À cells were exposed to nocodazole, taxol and vinblastine, different microtubule disrupting drugs and the levels of Lats2 were determined (Figure 3c ). Again, high basal levels of Lats2 and very marginal effects of all drugs were observed in Fbw7 À/À cells suggesting that the limited induction is not drug specific. The high basal levels of Lats2 might be due to chronic induction, caused by chromosomal abnormalities in the Fbw7 À/À cells, a phenomenon described by others (Rajagopalan et al., 2004) and confirmed here (Supplementary Figure  S2) . In fact, we observed particularly high levels of nuclear Lats2 in cells exhibiting visible genomic abnormalities (Supplementary Figure S2) .
One possible interpretation of these results is that p53 transcriptional activity in the Fbw7 À/À cells had already reached its maximal capacity and therefore could not be further augmented by vinblastine. To address this possibility, Fbw7
À/À and Fbw7 þ / þ cells were treated with vinblastine or the DNA-damaging agent neocarzinostatin (NCS) for 24 h, after which p21 cip1 mRNA levels were examined by qRT-PCR. In line with earlier data, p21 cip1 mRNA was only mildly induced in Fbw7
À/À cells following exposure to vinblastine (Figure 3d ), nevertheless, NCS could still dramatically induce p21 cip1 mRNA in Fbw7 À/À cells, indicating that the failure of these cells to further activate p53 is restricted to mitotic poisons. To examine whether Fbw7 deficiency affects p53 by alteration of its activating phosphorylation in Ser 15 we exposed Fbw7 À/À and Fbw7 þ / þ cells to vinblastine or taxol and determined the changes in Ser 15 phosphorylation at 12 and 24 h after treatment. p53 was phosphorylated at Ser 15 also in Fbw7
À/À cells after exposure to vinblastine but not after taxol treatment (Figure 3e ). Since both drugs drive the cells to polyploidy it does not seem likely that this is the mechanism responsible for compromising the p53 activity.
Overexpression of either cyclin E or Aurora A alone is not sufficient for drug-induced polyploidy Deregulation of cyclin E or Aurora A might account for the drug-induced polyploidy, since overexpression of either protein has been reported previously to induce genomic instability under other conditions (Spruck et al., 1999; Meraldi et al., 2002; Anand et al., 2003) . To determine which pathway could account for the ability of Fbw7 À/À cells to polyploidize, we examined the ploidy when only single factor was elevated at a time. We took advantage of the fact that Aurora A levels are elevated in cells heterozygous for Fbw7, equivalently to or even higher than those expressed in Fbw7 À/À cells (Supplementary Figure S3) , whereas cyclin E levels remain normal (Figure 4a ). Despite the high levels of Aurora A in the Fbw7 À/ þ , these cells responded similarly to Fbw7 þ / þ cells after exposure to vinblastine or taxol (Figure 4c ), suggesting that elevated levels of Aurora A are not in themselves sufficient to drive HCT116 cells to undergo drug-induced polyploidization. To examine the effect of cyclin E overexpression on drug-induced polyploidy, we stably transfected cells with an expression vector for hyperstable cyclin E (E-380). Analysis of several lines confirmed the increased expression of cyclin E, as represented in Figure 4b . However, treatment with vinblastine or taxol did not increase polyploidy in any of these cell lines (Figure 4c ). Of particular note was a single cell clone that expressed exceptionally high amounts of cyclin E and was rendered tetraploid even without exposure to drugs. However, upon treatment with vinblastine or taxol, these cells arrested properly and did not undergo endoreduplication (data not shown), further emphasizing that overexpression of cyclin E is by itself not sufficient to override the tetraploidy checkpoint in these cells. Lastly, since the compromised activity of p53 might in itself affect the tetraploidy checkpoint and the propensity of Fbw7 À/À cells toward polyploidy, we examined the effects of vinblastine and taxol treatments on HCT116 and HCT116 p53 À/À cells (Waldman et al., 1996) . Surprisingly, at these relatively early time points (24-40 h), cells lacking p53 arrested at rates similar to p53 þ / þ and Fbw7 þ / þ cells (Figure 4c ). In contrast, analysis 72 h after vinblastine treatment revealed a À/À and Fbw7 þ / þ cells were treated with 100 nM vinblastine or 100 nM taxol harvested at the indicated times and the levels of cyclin B, phospho-histone 3 (Ser 10), BUBR1 and p27 were determined by immunoblotting using specific antibodies. Total actin level served as a loading control.
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cells relative to wild-type cells (data not shown), indicating that in HCT116 cells, the lack of p53 expression results in an increase in polyploidy that is less severe than Fbw7 deficiency. These results suggest that deregulation of either cyclin E, Aurora A or p53 alone is not sufficient for duplication of the Fbw7
phenotype following exposure to mitotic inhibitors.
Overexpression of both Aurora A and cyclin E is required for drug-induced polyploidization The results depicted in Figure 4 demonstrate that, acting individually, neither cyclin E nor Aurora A is sufficient for overriding the tetraploidy checkpoint in HCT116 cells. However, which of these factors is required for polyploidization? To address this issue, we reduced the expression of each of these proteins by infection of Fbw7 À/À cells with retroviral vectors expressing shRNA directed against either cyclin E or Aurora A. Cells were then treated with taxol or vinblastine and DNA content was determined. Introduction of cyclin E shRNA reduced the expression of the endogenous protein by 42% (Figure 5a ). It is noteworthy that despite stable virus integration, the silencing effect of the shRNA was transient (data not shown), demonstrating the strong selective pressure for maintaining high levels of cyclin E in these cells. Nevertheless, the modest downregulation of cyclin E in Fbw7 À/À cells was sufficient to reduce drug-induced polyploidization, diminishing the fraction of cells with more than 4 N DNA content by 55 or 41% after treatment with vinblastine or taxol, respectively (Figure 5c ). Similar results were obtained by silencing Aurora A. In this case, the shRNA reduced the expression of the protein by almost 60% (Figure 5b) , and inhibited polyploidization by 62 and 40% after treatment with vinblastine or taxol, respectively (Figure 5c ). We, therefore, conclude that the excessive activities of both cyclin E and Aurora A are required for overriding the mitotic arrest. þ / þ and Fbw7 À/À cells were treated with 8 ng/ml nocodazole (Noc), 100 nM taxol or 100 nM vinblastine and harvested 8 h after treatment. The levels of Lats2 were determined by immunoblotting using specific antibodies. GAPDH served as a loading control. (d) Relative expression of p21 cip1 mRNA before (empty bars), and 24 h after treatment with 100 nM vinblastine (black bars) or 200 mg/ml neocarzinostatin (NCS) (striped bars) were determined by real-time PCR. Hypoxanthine-guanine phosphoribosyl transferase (HPRT) levels were used to normalize the p21 cip1 mRNA levels. P-values are Fbw7 þ / þ ±vinblastine, 0.0035; Fbw7 þ / þ ±NCS, 0.001; Fbw7 À/À ±vinblastine, 0.0006; Fbw7 À/À ±NCS, 0.0004. (e) Fbw7 À/À and Fbw7 þ / þ cells were treated with 100 nM vinblastine or 100 nM taxol harvested at the indicated times and the levels of phospho-Ser 15-p53 was determined by immunoblotting with a specific antibody.
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Fbw7 regulates p53-dependent induction of Lats2 and p21 cip1 and elevated levels of Lats2 can inhibit drug-induced polyploidization Together with a study describing the emergence of Fbw7 mutations during tumorigenesis in p53 þ /À but not p53
mice (Mao et al., 2004) , our results suggest a molecular cross talk between Fbw7 and p53. Previous studies have placed Fbw7 downstream of p53 (Kimura et al., 2003) . Given the limited induction of p21 cip1 and Lats2 by vinblastine in cells lacking Fbw7, we examined the possibility that Fbw7 might also function upstream of p53 to regulate the transcriptional activity of p53 in response to mitotic inhibitors. For that end, Fbw7 À/À cells were transfected with an expression vector for Fbw7a, and the levels of p21 cip1 and Lats2 were measured after vinblastine treatment. Overexpression of Fbw7a reduced the basal level of Lats2 and p21 cip1 by 1.4-and 2.5-fold, respectively (Figures 6a and b) . More importantly, Fbw7a overexpression restored the ability of these genes to be induced by vinblastine, and actually enabled a 2.5-fold induction of Lats2 and a 4.7-fold induction of p21 cip1 . Moreover, the total levels of Lats2 and p21 cip1 after vinblastine exposure were higher in Fbw7 overexpressing cells than in non-expressing cells. These results suggest that Fbw7 affects the induction of both Lats2 and p21 cip1 by vinblastine. To directly test the dependency of the induction on p53, Fbw7 was co-transfected into Fbw7
À/À cells together with p53 shRNA. Knockdown of p53 prevented the induction of Lats2 and p21 cip1 in Fbw7-transfected cells following exposure to vinblastine (Figures 6a and b) , demonstrating that their induction is p53 dependent. À/À cells expressing shRNA for cyclin E (striped bars), or Aurora A (dotted bars) were treated with 100 nM vinblastine or 100 nM taxol and harvested 24 or 40 h after treatment, respectively. The fraction of cells containing more than 4 N chromosomes was determined by fluorescence-activated cell sorting (FACS) analysis. P-values are Fbw7
À/À ± vinblastine, 0.005; ± taxol, 0.001; Fbw7 À/À Sh-cyclin E ± vinblastine, 0.019882; ± taxol, 0.00198. Fbw7 À/À Sh-Aurora A ± vinblastine, 0.007392; ± taxol 0.005095.
Next, we questioned whether reinforcement of the p53 pathway, whose responsiveness is attenuated in the absence of Fbw7, is able to enforce arrest once the polyploidy checkpoint is activated. For that end, Lats2 was stably overexpressed in Fbw7 À/À and Fbw7 þ / þ cells, and their responses to taxol were monitored. Lats2 was chosen since it specifically regulates the p53 response to mitotic stress (Aylon et al., 2006) , and Fbw7 affects its induction (Figure 6a ). The levels of ectopic Lats2 in the transfected cells were approximately fourfold higher than the endogenous levels (Figure 6c) . Overexpression of Lats2 did not significantly affect the cell cycle distribution of untreated Fbw7 þ / þ or Fbw7 À/À cells (Figure 6d ). However, after exposure of Fbw7 À/À cells to taxol, the effects of Lats2 were clearly evident (Figure 6d) . Most remarkable was a more than fourfold reduction in the fraction of polyploid cells 48 h after treatment, from 36.7% in vector-expressing cells to 9.1% in Lats2-expressing cells. This decrease was accompanied by a significant increase in the amount of cells arrested with 4 N DNA content. For example, 48 h after treatment the fraction of cells arrested with 4 N DNA content was doubled by Lats2 expression in Fbw7 À/À cells, whereas only a 1.25-fold increase was observed by Lats2 overexpression in Fbw7 þ / þ . These results demonstrate that Fbw7 can enhance p53 activity, and that elevated p53 activity can compensate for Fbw7-dependent polyploidy.
Lastly, we wished to verify that the effects observed on polyploidy and on gene expression in the Fbw7 À/À cells are indeed due to the lack of Fbw7 and not to some nonspecific events that might have occurred during the generation of the cell line. We transiently co-transfected Fbw7 À/À cells with green fluorescent protein (GFP)-expression vector together with Fbw7a-expression vector or empty vector, treated for 48 h with vinblastine and the cell cycle distribution of GFP-positive cells was analysed by fluorescence-activated cell sorting (FACS). Transfection of Fbw7 reduced the fraction of polyploid cells by more than 50%, from 28.7 to 12.5% (Figure 7a) . Hence, the augmented polyploidization of Fbw7-deficient cells after vinblastine treatment is indeed due to Fbw7 deficiency.
Discussion
Drug-induced abnormal spindle assembly activates the spindle assembly checkpoint, which arrests cells in mitosis. Exit from the imposed growth arrest by mitotic slippage, without sister chromatid segregation or cytokinesis, is a well-documented phenomenon. Consequent activation of p53 serves as a safeguard mechanism to prevent polyploidization. Some proteins involved in overriding the mitotic checkpoint have been described. In addition, cyclin B destruction was demonstrated to occur in the presence of an active checkpoint to enable mitotic checkpoint slippage (Brito and Rieder, 2006 and Figure 2) .
Here, we demonstrate that Fbw7 is a master regulator of the mitotic and G 1 checkpoints. In its absence (Fbw7 À/À cells) or after considerable reduction in its expression (HeLa shRNA), significant mitotic slippage and endoreduplication occur after exposure to spindle toxins (Figures 1 and 2) . Interestingly, expression of a single copy of Fbw7 is sufficient to prevent drug-induced polyploidy (Figure 4) , demonstrating a haplosufficient phenotype. We suggest that Fbw7 negatively regulates mitogenic signaling on the one hand, and acts upstream to p53 to enhance its response to mitotic inhibitors on the other hand, as depicted in Figure 7b . It is unclear, if the lack of p27 induction by the spindle toxins in Fbw7 À/À cells contributes to their polyploidization since in other experimental setting p27 was shown to contribute to endoreduplication . In addition, further studies are required to define the relations between p27 and Fbw7. It is noteworthy, however, that these cells express high levels of cyclin E that may promote p27 degradation by enhancement of its phosphorylation on Thr 187 in combination with Cdk2 (Sheaff et al., 1997; Vlach et al., 1997; Montagnoli et al., 1999) . In addition to cyclin E, inactivation of Fbw7 also augments the activity of Aurora A, both are known to be involved in the induction of polyploidy and genomic instability (Spruck et al., 1999; Meraldi et al., 2002; Anand et al., 2003) .
Cyclin E overexpression results in genomic instability which is mainly characterized by the appearance of micronuclei and spindle dysfunction and abnormal chromosome segregation in Fbw7 À/À cells (Rajagopalan et al., 2004) . Furthermore, cyclin E controls the ability of placental trophoblast giant cells to endoreduplicate (Parisi et al., 2003) . However, several evidences suggest that the high expression of cyclin E in the Fbw7 À/À cells is not sufficient for overriding the drug-induced mitotic arrest. First, without drug exposure Fbw7 (Rajagopalan et al., 2004) ). The drugs increase polyploidization specifically in Fbw7 À/À cells without further induction in cyclin E levels ( Figure 3) . Second, overexpression of cyclin E in Fbw7 þ / þ cells, at levels equivalent to those found in Fbw7 À/À cells, did not increase polyploidy post-treatment (Figure 4) . Lastly, enforced expression of cyclin E does not impair G 1 and G 2 checkpoint controls in human primary fibroblasts (Minella et al., 2002) . Therefore, we suggest that the high level of cyclin E is essential but is not a sufficient mechanism to regulate the drug-induced polyploidization, particularly when the p53 pathway is still intact (Minella et al., 2002 (Minella et al., , 2007 . In vivo studies revealing that mutations in Fbw7 correlate with polyploidy and aneuploidy, yet elevated expression of cyclin E does not, support our conclusion (Hubalek et al., 2004) . Aurora A which is frequently overexpressed in breast, colon and other types of cancers (Tanaka et al., 1999; Takahashi et al., 2000; Gritsko et al., 2003) is also involved in most aspects of mitosis, including centrosome maturation, separation, bipolar-spindle assembly and chromosome alignment (reviewed in (Marumoto et al., 2005) . We found that the elevated levels of Aurora A following inactivation of a single Fbw7 allele were not sufficient to drive the cells to polyploidy (Figure 4) . In HCT116 cells, neither cyclin E alone nor Aurora A alone was sufficient to induce polyploidy; rather, both were required, together. Accordingly, shRNA-mediated downregulation of either protein-inhibited drug-induced polyploidization ( Figure 5 ).
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The relationship between Fbw7 and the p53 pathway has been previously described. Fbw7 is mutated in tumors derived from irradiated p53 þ /À cells (Mao et al., 2004) , and p53 regulates the expression of Fbw7b (Kimura et al., 2003) . Thus, previous observations assigned p53 to a role upstream of Fbw7 (Mao et al., 2004) . Given the ability of Fbw7 to elevate the levels of p53 target genes upon vinblastine treatment, we suggest that Fbw7 also acts upstream of p53. This could explain the requirement for Fbw7 inactivation in cells expressing at least one allele of p53 and not in p53-null mice (Mao et al., 2004) . Our model suggests that the oncogenic overload of Fbw7 À/À cells requires high basal activity of p53 to counteract it and maintain a relatively normal cell cycle profile (Figures 1 and 3) . However, once the cell is exposed to mitotic inhibitors which increase the pressure for polyploidization, further activity of p53 is required, that Fbw7 À/À cells are unable to provide, resulting in polyploidization. Indeed, reintroduction of Fbw7 into Fbw7-deficient cells restored the ability of vinblastine to induce Lats2 and p21 cip1 ( Figure 6 ). Furthermore, elevated levels of Lat2, whose induction was at least partially affected by Fbw7 expression, inhibited drug-induced polyploidy. It is conceivable that the missing link connecting Fbw7 and the p53 pathway is Aurora A, which interacts and phosphorylates both Lats2 and p53 (Katayama et al., 2004; Liu et al., 2004; Toji et al., 2004) . However, the existence of additional yet unknown Fbw7-controlled proteins that affect the p53 pathway is not excluded. The model presented in Figure 7b illustrates the suggested mode of action of Fbw7 in the prevention of polyploidy. We propose that the interactions depicted in this model play an important role in mediating the tumor suppressor activity of Fbw7.
Materials and methods

Cell lines
À/À and HCT116 p53 À/À were kindly provided by Dr B Vogelstein and have been described previously (Waldman et al., 1996; Rajagopalan et al., 2004) . The cells were grown in McCoy's modified medium supplemented with 10% fetal bovine serum.
Plasmids and antibodies H-79 polyclonal anti-c-Jun, polyclonal anti-KPM/Lats2, C-19 polyclonal anti-p27 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), 9B11 monoclonal anti-Myc, polyclonal anti-Aurora A/AIK, polyclonal anti-phospho-Ser 15 p53, polyclonal phospho-histone H3 (Ser 10) (Cell Signaling, Danvers, MA, USA), HE12 monoclonal anti-cyclin E (Calbiochem, San Diego, CA, USA), V152 monoclonal anticyclin B (Abcam, Cambridge, UK), SMP14 anti-Hdm2, C4 monoclonal anti-pan actin (MP Biomedicals Inc., Solon, OH, USA), G9295 anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) monoclonal (Sigma, St Louis, MO, USA) and pAB421 or DO1 anti-p53 monoclonal antibodies were used to detect the corresponding proteins by western analyses and immunofluorescence.
Retroviral vectors expressing shRNA for silencing of Aurora A and cyclin E were kindly provided by Dr K Nakayama and were described previously (Fujii et al., 2006) . The vector for expression of shRNA against Fbw7 was kindly provided by Dr B Clurman. The expression vector for 6 Â Myc-Lats2 was previously described (Toji et al., 2004) . The expression vector for the hyperstable form of cyclin E was kindly provided by Dr M Madryj, and has been described previously (Libertini et al., 2005) . þ / þ and Fbw7 À/À cells were co-transfected with combinations of plasmids including vector or Fbw7-expression vector together with shRNA against either Lacz or p53. Puromycin resistance gene was added to every transfection. The transfected cells were briefly selected by exposure to puromycin, and afterward exposed for 16 h to 100 nM vinblastine. Expression of Lats2 mRNA (a) and p21 (b) in treated or untreated cells was determined by real-time PCR. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA levels served as loading control for normalization. P-values for the results presented in a are Sh-Lacz±vinblastine, 0.32; ShLacz þ Fbw7±vinblastine, 0.0014; Sh-p53±vinblastine, 0.1; Sh-p53 þ Fbw7, 0.069. P-values for the results presented in (b) are Sh-Lacz ± vinblastine, 0.17; Sh-Lacz þ Fbw7 ± vinblastine, 0.0002; Sh-p53 ± vinblastine, 0.029; Sh-p53 þ Fbw7 ± vinblastine, 0.021 (c) Fbw7 þ / þ and Fbw7 À/À cells were stably transfected with Myc-tagged Lats2. Expression of endogenous and exogenous Lats2 was determined by immunoblotting 8 h after treatment with 100 nM taxol. (d) Fbw7
þ / þ and Fbw7 À/À cells expressing or not ectopic Lats2 were exposed to 100 nM taxol for the indicated time (hours) and cell cycle was determined by fluorescence-activated cell sorting (FACS) analysis.
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Isolation of RNA and real-time PCR Sequences of primers used for qRT-PCR were described previously (Aylon et al., 2006) . For analysis of Fbw7 mRNA expression, the following primers were used: 5 0 -GACCTCA GAACCATGGTCCAACTT-3 0 and 5 0 -AGTAGTATGTG GACCTGCCCGTT-3 0 . In all cases, the results presented are normalized for GAPDH or hypoxanthine-guanine phosphoribosyl transferase (HPRT) expression.
FACS analysis
A total of 3 Â 10 5 cells per 6 cm dish were plated. Vinblastine or taxol (100 nM) were used to treat the cells, unless indicated otherwise. Both floating and adherent cells were collected, fixed with methanol and stained with 25 mg/ml propidum iodide. DNA content was determined using FACS scan. Each experiment was repeated at least three times.
